CareLit Fachartikel
Short-acting antipsychotics or long-acting injectables? A treatment comparison in patients with schizophrenia
N.N. · Gesundheitsökonomie & Qualitätsmanagement · 2020 · Heft 3 · S. 170 bis 178
Dokument
251706
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Abstract Aim This research aims to compare the efficacy and direct costs of short-acting oral antipsychotics and aripiprazole once-monthly (AOM) in the context of the treatment of patients with schizophrenia based on real-world data in Germany. Method Results are based on a single-armed, retrospective, non-interventional pre-post comparison study evaluating data from 132 patients with schizophrenia before and after switching from oral antipsychotics to AOM treatment (6 months each). Socio-demographics, as well as parameters of indication, efficacy and resource consumption were analyzed and statistically evaluate…
Schlagworte
AMBULANZ
TAGESKLINIK
KOSTEN
PATIENT
VERWEILDAUER
DEUTSCHLAND
ANTIPSYCHOTIKA
PATIENTEN
SCHIZOPHRENIE
Gesundheitsökonomie & Qualitätsmanagement
